Brief: Sesen Bio - Will Receive A $20 Million Milestone Payment Pursuant To Co’S Exclusive License Agreement With F. Hoffmann-La Roche Ltd & Hoffman-La Roche Inc
06/01/2022 13:54
Jan 6 (Reuters) - Sesen Bio Inc SESN.O :
* SESEN BIO - WILL RECEIVE A $20 MILLION MILESTONE PAYMENT
PURSUANT TO CO’S EXCLUSIVE LICENSE AGREEMENT WITH F. HOFFMANN-LA
ROCHE LTD & HOFFMAN-LA ROCHE INC
* SESEN BIO - CURRENTLY EXPECTS THAT ITS CASH AND CASH
EQUIVALENTS
WILL BE SUFFICIENT TO FUND ITS CURRENT OPERATING PLAN INTO 2024
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Carisma Therapeutics
See all newsBrief: Carisma Therapeutics & Modernatx Amend Collaboration & And License Agreement - SEC Filing
Carisma Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Carisma Therapeutics Inc expected to post a loss of 9 cents a share - Earnings Preview
Brief: Carisma Therapeutics And Orthocellix Enter Into Definitive Merger Agreement
Carisma Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary